Lab Test Details
SIM |
21245 |
85520 | |
Heparin Anti-Xa; Antifactor Xa; Heparin Assay | |
Plasma | |
Blue-top sodium citrate tube. |
|
Blood is to be collected in a blue-top tube containing 3.2 % buffered sodium citrate. Evacuated collection tubes must be filled to completion to ensure a proper blood to anticoagulant ratio. Sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of specimen and anticoagulant. Place specimen on ice to deliver to laboratory. |
|
1 mL plasma (not blood volume) |
|
Determine the plasma level of unfractionated heparin (UFH) or low molecular weight heparin (LMWH). Historically, many laboratories have monitored heparin levels using the PTT. A large number of conditions can complicate the use of the PTT in monitoring therapy. In these cases, the anti-Xa assay may be more appropriate for monitoring heparin therapy. |
|
Heparin anti-Xa levels should be drawn 6 hours after initiation of unfractionated heparin therapy, or change in dose, whereas with low molecular weight heparin, levels should be drawn 6 hours after administration if once daily and 3-4 hours if twice daily. |
|
Once delivered to the laboratory on ice, the specimen is centrifuged ASAP and the plasma carefully removed and frozen. |
|
Frozen |
|
Specimens not received in lab on ice; quantity not sufficient; blue top tube not filled properly;gross hemolysis. |
|
Reference Range accompanies report |
|
Plasma level of heparin. | |
Based on the ability of heparin to inhibit the activity of activated factor X (Xa) in the reagent. The reagent includes excess antithrombin, making the heparin in the sample the rate limiting reagent for Xa inhibition.Standard curves are created using multiple concentrations of UFH and LMWH and are used to calculate concentration in the patient plasma. | |
117101 | |
Rhonda Crowe | |
4/1/22 | |
* Denotes reference test* |